SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-19-129466
Filing Date
2019-04-30
Accepted
2019-04-30 16:30:57
Documents
8
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d714799d10ka.htm 10-K/A 1221140
2 EX-31.1 d714799dex311.htm EX-31.1 2721
3 EX-31.2 d714799dex312.htm EX-31.2 2727
4 GRAPHIC g714799g10c17.jpg GRAPHIC 57300
5 GRAPHIC g714799g12n08.jpg GRAPHIC 58838
6 GRAPHIC g714799g24v10.jpg GRAPHIC 63025
7 GRAPHIC g714799g73m59.jpg GRAPHIC 41273
8 GRAPHIC g714799g80s73.jpg GRAPHIC 36397
  Complete submission text file 0001193125-19-129466.txt   1582288
Mailing Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL 44 0 1707 853 000
Mylan N.V. (Filer) CIK: 0001623613 (see all company filings)

IRS No.: 981189497 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-199861 | Film No.: 19782253
SIC: 2834 Pharmaceutical Preparations